News
Neuralink’s PRIME2 study adds chronic ischemic stroke
Up to 10 participants at up to five sites. The University of Miami is recruiting. ALS and spinal cord injury remain in the study.
The Elonomist desk
- Published
- Updated
Last verified
PRIME2, a new US early feasibility study of the N1 implant, adds chronic ischemic stroke to ALS and spinal cord injury. The study lists up to 10 participants at up to five sites. The University of Miami is recruiting.
Sources
- 1